GW Pharmaceuticals PLC ADR (GWPH)

219.01
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    219.48/219.94
  • Day's Range:
    218.60 - 219.45

GWPH Comments

What is your sentiment on GW Pharmaceuticals PLC ADR?
or
Market is currently closed. Voting is open during market hours.

All Comments

(92)
  • 3 weeks now, absolutely no movement whatsoever.
    0
    • JA/ZZ bought this company out - both are going under
      1
      • bubbles . sell
        2
        • sell or you will lose money like in gme
          2
          • sell?! are you crazy?! it haven't hit it stride.
            0
        • puts????
          0
          • idk bro its up to you
            0
          • Zachary Marascothanks bro
            0
        • I bought some time ago and meant to keep it for long time, but I am thinking, should I take the profit now? And reinvest when drops?
          2
          • defo
            1
        • Woot woot!!!
          0
          • going up now
            0
            • it seems we are on the major support
              0
              • As all wait Zynerba’s Zygel FDA approval for Fragile X, GW is a bit depressed of course. I think this depression will continue till that, and after approval GW and Zynerba will grow together.
                0
                • *think
                  0
                • Sure. But for Zynerba more, because their solution better tolerated and has weaker side effects (and their market cap looks undervalued). But more approved drugs with CBD - stronger potential for the whole market.
                  0
                • I think also as both companies will reach plase 3 in ASD, this huge market will asquire all the players
                  0
              • whats wrong with this? it has a good tp but is sleeping
                0
                • is this the best cannabis stock?
                  0
                  • best moment to buy the dip
                    0
                  • fine but you think this could be the best performer in next years I wanna build a eed position
                    0
                  • *****
                    0
                • $122 soon
                  0
                  • target to this month $127
                    0
                    • target 110
                      0
                      • On the green again
                        0
                        • JP Morgan target $190+ to GW Pharma https://www.investing.com/news/jp-morgan-stick-to-their-buy-rating-for-gw-pharma-2272981
                          0
                          • JP Morgan say BUY to GW Pharma https://www.investing.com/news/jp-morgan-stick-to-their-buy-rating-for-gw-pharma-2272981
                            0
                            • Zacks price, consensus and EPS surprise https://www.zacks.com/stock/chart/GWPH/price-consensus-eps-surprise-chart
                              0
                              • next target $125
                                0
                                • Sundial growers next week 1,5 $
                                  0
                                  • This will soar for aure. Leading compny, only fda approval A M A Z I N G
                                    0
                                    • 🚀
                                      0
                                  • A beautiful cup and handle followed by an inverse head and shoulder suggesting a breakout above 133 - Buy long
                                    0
                                    • buy long
                                      0
                                      • Buy buy buy! Been long since march . Made well over 200k and still have 2/3 in...
                                        0
                                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.